The KCNJ11 gene has attracted considerable attention as a promising candidate for T2D based on its position and its function as a key factor in the regulation of glucose-induced insulin secretion, since normoglycemic lysine carriers are shown to consistently display a defect in insulin secretion [21], [63], [64]. The gene discussed is KCNJ11; the disease is type 2 diabetes mellitus.